Postoperative Analgesia y After Uniportal Video-assisted Thoracoscopic Surgery

February 23, 2023 updated by: National Cheng-Kung University Hospital

Comparison of Surgical Thoracoscopic Intercostal Nerve Block and Ultrasound-guided Erector Spinae Plane Block for Postoperative Analgesia and Enhanced Recovery After Uniportal Video-assisted Thoracoscopic Surgery: a Double-blinded, Randomized Controlled Trial

Ultrasound-guided erector spinae plane block (ESPB) is an interfascial blockade during thoracic anesthesia, first described by Forero in 2016, and is highlighted by technically feasibility and less complication rate. The patient is placed as decubitus position. The anesthesiologists use echo to identify the ipsilateral transverse process at T5 level, and insert the needle to 2-3 cm lateral to the spinous process until contact the transverse process. Then the injected local anesthetic will penetrate via erector spinae muscle to paravertebral space to affect and relieve pain.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan
        • Recruiting
        • National Cheng Kung University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients, over 20 years old, u
  • undergoing elective uniportal VATS lobectomy.

Exclusion Criteria:

  • patient refusal,
  • body mass index > 35 kg/m2,
  • American society of anesthesiologists (ASA) grade above 3,
  • contraindication to nerve block,
  • allergy to analgesic agents,
  • regular opioid used for chronic pain prior to this time surgery,
  • conversion to thoracotomy or VATS procedure,
  • postoperative intubation,
  • postoperative intensive care unit admission.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: post-operative VAS score of Ultrasound-guided erector spinae plane block
Ultrasound-guided erector spinae plane block
Active Comparator: post-operative VAS score of surgical thoracoscopic intercostal nerve block
surgical thoracoscopic intercostal nerve block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue scale
Time Frame: post-op 2 days
post-op VAS score, 0-10, the higher means painful, and "0" point no pain.
post-op 2 days
accumulated morphine usage dose
Time Frame: post-op 2 days
accumulated morphine usage dose
post-op 2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2021

Primary Completion (Anticipated)

December 26, 2024

Study Completion (Anticipated)

December 26, 2024

Study Registration Dates

First Submitted

January 26, 2022

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 16, 2022

Study Record Updates

Last Update Posted (Estimate)

February 27, 2023

Last Update Submitted That Met QC Criteria

February 23, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thoracic Diseases

Clinical Trials on Ultrasound-guided erector spinae plane block

3
Subscribe